%0 Journal Article
%T Trends in clinical trials for articular cartilage repair by cell therapy
%A Akifumi Matsuyama
%A Hanayuki Okura
%A Takaharu Negoro
%A Yuri Takagaki
%J Archive of "NPJ Regenerative Medicine".
%D 2018
%R 10.1038/s41536-018-0055-2
%X Analysis of projects in ClinicalTrials.gov according to the cell source organ used for cell therapy and cartilage repair. ¡°Others¡± include studies that are using multiple cell sources for combination or comparison. a Percentage of each cell source relative to the total number of studies. b Comparison of number of clinical trials on cartilage repair according to countries of origin. Each color-coded part of the bar depicts the corresponding cell-source organ by country. The top 12 countries are shown in this graph. c Each study was color-coded by the corresponding cell source organ and displayed from the start year to the (planned) completion year, sorted by start year in chronological order. Shaded column: current year (2018) to 2025. Since 2018, a trial bar displays if the trial is registered. Please note that we could not show if the trial continued or was halted prematurely. Red-dashed column: 2014¨C15. Vertical-striped bar indicates ¡°suspended,¡± ¡°terminated,¡± or ¡°withdrawn¡± stud
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181982/